ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
22 announcements with these filters
Sharda Cropchem Ltd held its 23rd AGM on August 14, 2026. Shareholders adopted financial statements and approved a final dividend of Rs. 9.00 per share.
Sharda Cropchem reported Q1 FY27 revenue growth of 9% YoY to Rs 1,074 crores. EBITDA grew 25% to Rs 178 crores with margins expanding to 16.6% despite FX headwinds.
Sharda Cropchem reported Q1 FY27 revenue of ₹1,074 crore, up 9% YoY. EBITDA grew 25% YoY to ₹178 crore.
Sharda Cropchem reported Q1 FY27 revenue of ₹1,074 Cr (+9% YoY) and EBITDA of ₹178 Cr (+25% YoY). The company continues to leverage its asset-light, IP-led registration model.
Sharda Cropchem Ltd reported revenue from operations of ₹1,074 Cr (+9.0% YoY) and net profit of ₹88 Cr (-38.4% YoY) for Q1 FY27.
Sharda Cropchem Limited will hold a board meeting on July 29, 2026, to consider unaudited standalone and consolidated financial results for the quarter ending June 2026.
Sharda Cropchem submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational highlights for the period.
Sharda Cropchem submitted its FY 2025-26 Annual Report. The company scheduled its 23rd AGM for August 14, 2026, and fixed August 7 as the dividend record date.
Sharda Cropchem will hold its 23rd AGM on August 14, 2026, via video conferencing. The company fixed August 7, 2026, as the record date for final dividend.
Sharda Cropchem will hold its 23rd AGM on 14 Aug 2026 via VC. The record date for dividend is 7 Aug 2026.
Sharda Cropchem reports its best-ever financial year in FY26, driven by gross margin expansion and strong volume growth in Europe.
Sharda Cropchem submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no major non-compliances noted.
Sharda Cropchem recommended a final dividend of Rs. 9.00 per equity share for FY 2025-26. The payout remains subject to shareholder approval at the AGM.
Sharda Cropchem delivered strong FY26 results with a 22% revenue increase and 124% PAT growth. The company maintains an asset-light model focused on product registrations and global distribution across 80+ countries.
Sharda Cropchem recommended a final dividend of ₹9 per equity share for 2026. This distribution rewards shareholders following the board's approval on May 13.
Sharda Cropchem reported 22% revenue growth to ₹5,268 Crore for FY26. PAT more than doubled to ₹681 Crore, driven by strong volumes and improved product mix.
Sharda Cropchem Ltd reported revenue from operations of ₹2,065 Cr (+12.9% YoY) and net profit of ₹318.7 Cr (+56.5% YoY) for Q4 FY26.
Sharda Cropchem approved its FY26 audited financial results and recommended a ₹9.00 per share final dividend. The board meeting concluded with an unmodified audit opinion.
Sharda Cropchem Limited has scheduled a board meeting for May 13, 2026, to approve audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also consider a final dividend recommendation. The trading window for designated persons remains closed until May 15, 2026.
Sharda Cropchem Limited has scheduled a Board Meeting on May 13, 2026, to approve audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also consider declaring a final dividend. The trading window for company shares remains closed for designated persons until May 15, 2026.
Sharda Cropchem Limited has scheduled a Board Meeting for May 13, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 2026 and recommend a final dividend. The trading window remains closed until May 15, 2026.
Sharda Cropchem Ltd reported net profit of ₹145 Cr (+366.2% YoY) for Q3 FY26.